I've been keeping an eye on the US district court cases for patent infringements. In the past 6 days, Valeant have filed infringements against 5 different defendants for the generic Efinaconazole topical solution (Jublia). Namely;
Strides Pharma
Solaris Pharma
Par Pharmaceutical
Lupin Pharmaceuticals
Aurobindo Pharma
Acrux have yet to be mentioned in a case, however if I am reading it correctly, there will be some competition for generic Jublia. Hardly surprising given it's a US$200+ million pa. cherry. Whether each of these companies were also first to file is another question. Surely one would have to assume such diligence
.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)